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xercise Training
n Heart Failure
ontradictory or Conventional?*
tanley A. Rubin, MD, FACC
os Angeles, California
he paintings of the Belgian surrealist René Magritte (1898
o 1967) juxtapose 2 incongruous, illogical, or even contra-
ictory objects: a steam locomotive projecting from a
omestic fireplace (Time Transfixed, 1939); a bright day-
ime sky over a nighttime scene of a dimly lighted street
The Empire of Light, 1954); or a picture of a pipe with a
aption on the canvas that reads, in French, “This is not a
ipe” (The Treachery of Images, 1929). On the basis of
onventional wisdom, the current palette of therapy for
eart failure also would seem incongruous, illogical, or
ontradictory if it included exercise therapy. However,
hange is at hand.
See page 2329
onventional wisdom excluded the role of exercise train-
ng in the management of heart failure. The definition of
eart failure—inadequate cardiac output/function to meet
he metabolic demands of the body—efficiently fits the
ommonly reported and observed clinical symptom of re-
uced exercise capacity in patients with heart failure: the
eart cannot keep up with the needs of the body that
ncrease with physical activity. The measurement of func-
ional capacity, objectified by exercise testing with measure-
ent of maximal oxygen uptake (VO2max) as the hallmark of
ody metabolism, demonstrates progressive limitation with
he degree of heart failure (1). It serves, for example, to
dentify appropriate candidates for cardiac transplantation
nd to determine the degree of disability (2).
This limitation in exercise capacity was turned-around as
management paradigm: cardiology textbooks routinely
dvocated the restriction of physical activity and eschewed
xercise training in patients with heart failure. The inclusion
f an excellent chapter in a congestive heart failure textbook
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Department of Veteran Affairs, Greater Los Angeles Healthcare System,(
nd the Department of Medicine, UCLA School of Medicine, Los Angeles,
alifornia.3) that advocated limited exercise rehabilitation and train-
ng based on available evidence-based medicine perhaps
arked the tipping point away from the conventional view.
ubsequently, an American College of Cardiology/American
eart Association (ACC/AHA) guideline statement (2)
ecommended exercise training in patients with heart fail-
re. A formalized recognition of this recommendation is
art of the current ACC/AHA guidelines (4) for patients
ith current or prior symptoms of heart failure with reduced
ystolic function: exercise training is a Class I recommen-
ation (Level of Evidence B). What is the evidence basis for
his sea change in exercise training as therapy for heart
ailure, what are the limitations of the recommendations
both patient- and payer-centered), and what should clini-
ians now do with this information?
tudies of exercise training suggest some beneficial ef-
ects. The ACC/AHA statement (2), noted previously,
eviewed 15 exercise trials in systolic dysfunction heart
ailure that included from 17 to 99 patients (total of 426)
atients, the typical range of study patients in such trials.
hese trials used a wide range of training programs that
iffered by setting, types of activity, intensity, and duration,
he latter ranging from 4 to 24 weeks. It found a modest
mprovement in VO2max that occurred after a few weeks
range 12% to 31%) that was sustained for a number of
onths if the training program continued. A Cochrane
eview of 29 studies with 1,126 patients similarly reported
hat exercise training resulted (in the subset of studies
roviding data) in modest increases of VO2max (range 10%
o 30%), duration of exercise, work capacity, and distance on
he 6-min walk. Improvements in VO2max were greater for a
raining program of greater intensity and duration. Health-
elated quality of life improved in patients in 7 of 9 trials
hat measured this outcome (5). Although safety was not
tated as a primary objective of the studies included in this
eta-analysis, 17 of the trials stated that no adverse event
ccurred, whereas 1 trial reported complications associated
ith training, but these complications were confined to the
ost severe patients with ejection fractions 30%. A
ecently published meta-analysis identified 35 studies, pub-
ished between 1991 and 2004, that included 1,486 patients
nd found results similar to those reported previously in this
aper. In a subset of studies that included cardiac perfor-
ance, no benefit on ejection fraction or end-systolic
olume was found, whereas end-diastolic volume decreased
ignificantly, but only by approximately 1% (6).
As to the basis for these improvements in VO2max and
ther measures of exercise capacity, the major benefit of
xercise training is likely to occur through a partial reversal
f physical deconditioning, which is an invariable concom-
tant of severe heart failure. Deconditioning may directly or
ynergistically (with cardiac dysfunction) worsen many of
he adverse organ system changes that occur in heart failure:
keletal muscle mass and metabolism, vascular function
endothelial function, in particular, has been cited), respi-
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Editorial Comment June 19, 2007:2337–40atory function and gas exchange, thermoregulation, and
euroendocrine homeostasis (7–16). Although the targets of
xercise training are largely noncardiac, beneficial effects on
he heart may occur through circulatory coupling that we
ow understand and routinely accept as determinants of
ardiac function in heart failure.
he current study extends previous findings. The meta-
nalysis by Haykowsky et al. (17) in this issue of the Journal
overs some familiar ground—exercise capacity and VO2max
n heart failure training studies—but adds some new infor-
ation: effects on cardiac function and its relationship to
odality of exercise training. As a background to their
eport, there are 2 broad categories of exercise modalities
sed in trials of training effect. Studies incorporate either
endurance” (sometimes called “aerobic” or “dynamic” or
isotonic,” which use large muscle groups during either a
alking-type or cycling-type of exercise) training, whereas a
maller set of trials use “strength” (sometimes called “circuit”
r “weight”) training, or both types of training.
In their meta-analysis of 14 trials that included measure-
ent of cardiac performance in 812 patients, the authors
ound an overall improvement in both VO2max (20%) and
jection fraction (3% absolute). However, the authors
oted heterogeneity in their pooled outcome and sought to
etermine its basis. They found that endurance training
tudies demonstrated these beneficial effects, whereas stud-
es that used combined exercise modalities (i.e., both en-
urance and strength) did not. Furthermore, in the subset of
tudies that reported ventricular volumes, a decrease of
nd-diastolic and -systolic volumes occurred in those that
sed endurance training, whereas trials with combined
raining were inconclusive, although the smaller number of
atients who participated in such studies limited the
trength of the statistical analysis.
The authors concluded that aerobic exercise training
everses, to some extent, adverse ventricular remodeling in
ystolic dysfunction heart failure. However, a novel aspect of
heir study was the finding that strength (or combined
odality) training did not demonstrate favorable effects.
hey hypothesized that the heightened systolic and diastolic
ressure loading that occurs with strength training pre-
ented the beneficial effects of exercise observed in the
tudies included in their meta-analysis and could have
ffects on the outcomes reported in other pooled trials of
xercise training in heart failure patients. What are the
imitations of these trials, and what do they portend both for
uture research in and treatment of heart failure?
roblems in design of exercise trials limit interpretation
f outcome. Exercise training trials of heart failure enroll
mall numbers of patients, thereby requiring meta-analyses,
ith their limitations, to provide the statistical affirmation
hat we now require for evidence-based medicine. However,
nother prominent and seemingly insuperable problem pre-
ents itself in evaluating the true effect of exercise training:
tudies lack patient blinding. An unblinded patient enrolled
n a trial who is aware that his or her exercise training creatment arm may receive benefit or even perceive that an
utcome based on this treatment could benefit or please the
rial investigator, may promote an enhanced degree of
ooperative behavior that could influence outcome, the
o-called “Hawthorne effect” (18). Furthermore, although
raining sessions are not customarily viewed as “patient
are,” it is hard to ignore the therapeutic benefit of a visit
ith (or even the presence of) a caregiver, even if stated for
nother purpose. Patients could skew outcome by, for
xample, increased compliance in nonstudy treatments, such
s diet and medication, and thereby beneficially influence
tudy end points, especially because standard therapy with
ngiotensin-converting enzyme inhibitors and beta-blockers
ach improve exercise capacity, whereas the latter also
mproves ventricular function (19).
Another limitation is that many earlier studies were
onducted without maximal drug therapy. For example, in
he meta-analysis of Haykowsky (17), only 4 of the 14
tudies used beta-blockers in more than 50% of the study
opulation, and only 2 of 14 used beta-blockers in more
han 70%. Furthermore, I am not aware of any exercise
raining study that includes patients who have biventricular
acing. It will be important to observe the outcome of future
rials that incorporate all proven modalities of heart failure
s baseline therapy in both treatment arms of an exercise
raining study.
uture prospects for exercise training in heart failure.
he positive outcomes in exercise training studies on
O2max and, as reported in this issue of the Journal, on
entricular function, likely serve as surrogate markers for
ncreased functionality and decreased symptoms in patients
ith heart failure. Without minimizing the value of these
esults to quality of life, most contemporary studies of
reatments for heart failure emphasize “hard” end points
uch as the number of heart failure hospitalizations and
urvival. Most single-center exercise training studies of
eart failure patients did not include these end points, either
ecause of design or small sample size. However, a recent
uropean collaborative meta-analysis examined death from
ll causes in 805 patient data sets from 41 nonoverlapping
xercise training trials of heart failure. In these endurance
raining trials, exercise significantly reduced both mortality
nd death plus hospital admission with hazard ratios of 0.65
nd 0.72, respectively, and the upper bound confidence
ntervals 1.0 for both; that is, the outcomes were statisti-
ally significant (20).
Now, a large, multicenter, randomized National Heart,
ung, and Blood Institute-sponsored clinical trial has been
ndertaken to definitively assess the effect of exercise train-
ng on the clinically relevant end points of mortality,
ospitalization, and quality of life in patients with heart
ailure: HF-ACTION (Heart Failure: A Controlled Trial
nvestigating Outcomes of Exercise Training) (21). Subse-
uent to baseline assessment to determine whether they can
afely exercise, 3,000 patients are randomized to either usual
are or exercise training, the latter consisting of supervised
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June 19, 2007:2337–40 Editorial Commentacility-based endurance (cycling or walking) exercise train-
ng sessions. After completing the supervised sessions,
atients initiate, and then transition to, solely home-based
xercise, with some refresher sessions as reinforcement.
atients are followed for up to 4 years. A number of
ubstudies are planned. The outcomes of this study should
ave a profound effect on this issue.
linical recommendation for an exercise training pro-
ram. On the basis of the ACC/AHA statement, a litera-
ure review and my interpretation of the data, I have
ssembled for the clinician an outline of considerations in
tarting a patient who has heart failure due to systolic
ysfunction on an exercise training program (Table 1).
aution in initiating an exercise training program is
trongly advised because, compared with habitual exercisers,
atients who initiate exercise after being habitually seden-
ary demonstrate a 100-fold increased risk for infarction and
xercise Training Program in Heart Failure
Table 1 Exercise Training Program in Heart Failure
Indications
1. Systolic dysfunction heart failure due to ischemic or idiopathic
cardiomyopathy
Contraindications or delay in initiating
1. Recent hospitalization for, or clinically unstable, heart failure
2. Heart failure medication not optimized
3. Severe stenotic or primary regurgitant valvular heart disease
4. Significant intercurrent illness, not substantially resolved
5. Recent procedure that requires delay in starting exercise training (e.g.,
implantable cardioverter-defibrillator implantation delay to permit wound
healing)
6. Exercise testing results that would preclude safe exercise training (see
below)
7. Uncertain: New York Heart Association functional class IV, secondary severe
mitral or tricuspid regurgitation, uncontrolled atrial fibrillation, or primarily
paced cardiac rhythm
Evaluation before initiating exercise training
1. Training should be preceded by a formal exercise test that, at least,
includes vital sign, rhythm, symptom, and safety (e.g., gait instability)
monitoring, and estimates functional capacity by a low level protocol (e.g.,
Modified Bruce or Naughton Protocol) with attention to findings that would
prohibit exercise training
Modality and degree of exercise training
1. Modality: substantially endurance (also called “aerobic” or “dynamic” or
“isotonic”) exercise that involves dynamic movement of large skeletal
muscles (e.g., walking, treadmill, cycle ergometry, or light calisthenics)
2. Minimal recommendation (performed at home or in a medically
nonsupervised facility): 30 min, or as long as tolerated, of moderate
physical activity on most days of the week*
3. Advanced recommendation (performed initially in a medically supervised
facility): training based on percent functional level and/or percent heart rate
as determined from baseline study performed a few times a week†
Venue of training
1. Consider initiation in a medically supervised environment with personnel
trained in advanced cardiac life support and capable of
summoning/activating paramedics
2. If performed at home or in a nonmedical facility, patients should have a
responsible person in close proximity to assist them if an adverse event
occurs
Defined as effort level that does not cause the individual to sweat or become short of breath. †The
edical facility should have an organized and in-depth plan for an exercise training program of
ardiac patients.50-fold increase risk for sudden death (22,23). Unstatedonditions of this recommendation are the motivation of the
atient to participate in such a training program, to monitor
hemselves for side effects, and to avoid excessive anticipa-
ion of benefit. The latter is important because cultural and
edia bias present highly trained sports figures as attaining
erculean status, whereas the likely benefit of an exercise
raining program in a heart failure patient will be small.
Still another problem remains for the both provider and
atient: exercise training for patients with heart failure
urrently is not cost reimbursed by the Centers for Medicare
nd Medicaid for cardiac rehabilitation services for patients
ith heart failure in the absence of an acute ischemic event.
his is a barrier to nonhome programs, but one that may be
ddressed if the evidence base becomes sufficient to convince
ayers of its value, as perhaps could occur upon completion
f the HF-ACTION trial.
onclusions. So, is heart failure and exercise training
ontradictory or conventional? Looking forward to the likely
eneficial effect of exercise training, as well as additional
eneficial therapies available to treat heart failure, we may
ne day look upon such a patient and say, “This is not a
eart failure patient.”
eprint requests and correspondence: Dr. Stanley A. Rubin,
A-UCLA Medical Program, Cardiology (111E), VA Greater
os Angeles Healthcare System, 11301 Wilshire Boulevard, Los
ngeles, California 90073. E-mail: sarubin@ucla.edu.
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